(Q43713633)

26 November 2017

title

The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale and design (English)

1 reference

26 November 2017

1 reference

3

1 reference

26 November 2017

Pauwels RA

1

1 reference

26 November 2017

Busse WW

2

1 reference

26 November 2017

Pedersen S

4

1 reference

26 November 2017

Tan WC

5

1 reference

26 November 2017

Chen YZ

6

1 reference

26 November 2017

Ohlsson SV

7

1 reference

26 November 2017

Ullman A

8

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Contemporary Clinical Trials

26 November 2017

published in

1 reference

26 November 2017

volume

22

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

405-419

1 reference

Mucosal inflammation in asthma

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Airway mucosal inflammation even in patients with newly diagnosed asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Airway wall remodelling in asthma: a novel target for the development of anti-asthma drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Small airways dimensions in asthma and in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Airway wall remodelling: does it occur and what does it mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Physiologic measures: pulmonary function tests. Asthma outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Risk factors for the persistence of respiratory symptoms in childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Adult patients may outgrow their asthma: a 25-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Outcome of childhood asthma in mid-adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Efficacy of once- and twice-daily administration of budesonide via Turbuhaler as initial therapy in patients with mild persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Once-daily inhaled corticosteroids in children with asthma: nebulisation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler(R) in children with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled Flunisolide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Measuring compliance with inhaled medication in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Measuring efficacy and safety of different inhaled corticosteroid preparations☆☆☆★

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Posterior subcapsular cataract and inhaled corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

Congenital malformations after the use of inhaled budesonide in early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900144-1

7 January 2021

10.1016/S0197-2456(01)00144-1

Identifiers

DOI

1 reference

26 November 2017

1 reference